|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,380.50 JPY | +1.82% |
|
-0.15% | +9.57% |
| 07-31 | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-30 | Ono Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 1,119B 7.09B 6.14B 5.73B 5.26B 9.89B 675B 10.04B 67.22B 26.39B 338B 26.64B 26.05B | P/E 2027 * |
15.7x | P/E 2028 * | 17.8x |
|---|---|---|---|---|---|
| Enterprise Value | 918B 5.82B 5.04B 4.7B 4.31B 8.12B 554B 8.24B 55.18B 21.66B 278B 21.86B 21.39B | EV / Sales 2027 * |
2.02x | EV / Sales 2028 * | 1.96x |
| Free-Float |
80.98% | Yield 2027 * |
3.29% | Yield 2028 * | 3.26% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | +1.82% | ||
| 1 week | -3.13% | ||
| Current month | -0.15% | ||
| 1 month | -2.78% | ||
| 3 months | +2.81% | ||
| 6 months | -4.19% | ||
| Current year | +9.57% |
| 1 week | 2,264.5 |  | 2,393 |
| 1 month | 2,264.5 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 77 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.82% | -3.13% | +39.21% | -11.16% | 6.94B | |
| -0.31% | -2.80% | +21.93% | +70.77% | 49.14B | |
| +4.40% | +12.38% | +67.88% | +144.61% | 40.36B | |
| -0.89% | -0.18% | -1.54% | +21.00% | 12.53B | |
| +0.56% | -0.08% | +19.46% | +71.48% | 11.6B | |
| +0.19% | -0.57% | +33.08% | +134.53% | 9.07B | |
| +1.99% | +4.94% | +20.43% | +38.19% | 6.97B | |
| +0.40% | +4.05% | +12.51% | +183.63% | 6.72B | |
| +6.44% | +8.69% | -26.17% | +21.48% | 5.59B | |
| +0.54% | +1.54% | +37.29% | +99.73% | 4.55B | |
| Average | +1.51% | +1.58% | +22.41% | +77.43% | 15.35B | |
| Weighted average by Cap. | +1.48% | +1.60% | +31.57% | +88.78% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 455B 2.88B 2.49B 2.33B 2.14B 4.02B 274B 4.08B 27.32B 10.72B 138B 10.83B 10.59B | 445B 2.82B 2.44B 2.28B 2.09B 3.93B 268B 3.99B 26.72B 10.49B 134B 10.59B 10.35B |
| Net income | 71.42B 453M 392M 366M 336M 631M 43.1B 641M 4.29B 1.68B 21.6B 1.7B 1.66B | 62.78B 398M 344M 322M 295M 555M 37.89B 564M 3.77B 1.48B 18.99B 1.49B 1.46B |
| Net Debt | -200B -1.27B -1.1B -1.03B -942M -1.77B -121B -1.8B -12.04B -4.73B -60.62B -4.77B -4.67B | -248B -1.57B -1.36B -1.27B -1.17B -2.19B -150B -2.23B -14.92B -5.85B -75.08B -5.91B -5.78B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-07 | JP¥2,380.50 | +1.82% | 1,307,700 |
| 26-08-06 | JP¥2,338.00 | +1.61% | 1,513,200 |
| 26-08-05 | JP¥2,301.00 | -0.26% | 1,636,100 |
| 26-08-04 | JP¥2,307.00 | -1.30% | 2,047,600 |
| 26-08-03 | JP¥2,337.50 | -1.95% | 1,775,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
